Page last updated: 2024-10-16

4-hydroxybenzaldehyde and Ischemic Attack, Transient

4-hydroxybenzaldehyde has been researched along with Ischemic Attack, Transient in 1 studies

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yu, X1
Luo, Y1
Yang, L1
Duan, X1

Other Studies

1 other study available for 4-hydroxybenzaldehyde and Ischemic Attack, Transient

ArticleYear
Plasma metabonomic study on the effect of
    Molecular medicine reports, 2023, Volume: 28, Issue:5

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzaldehydes; Brain Ischemia; Infarction, Middle

2023